- Home
- RLAY vs BKSY Comparison
RLAY vs BKSY Comparison
Compare RLAY & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- BKSY
- Stock Information
- Founded
- RLAY 2015
- BKSY 2013
- Country
- RLAY United States
- BKSY United States
- Employees
- RLAY N/A
- BKSY N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- BKSY Radio And Television Broadcasting And Communications Equipment
- Sector
- RLAY Health Care
- BKSY Technology
- Exchange
- RLAY Nasdaq
- BKSY Nasdaq
- Market Cap
- RLAY 803.4M
- BKSY 699.0M
- IPO Year
- RLAY 2020
- BKSY N/A
- Fundamental
- Price
- RLAY $6.72
- BKSY $19.29
- Analyst Decision
- RLAY Strong Buy
- BKSY Strong Buy
- Analyst Count
- RLAY 8
- BKSY 5
- Target Price
- RLAY $17.25
- BKSY $29.00
- AVG Volume (30 Days)
- RLAY 2.0M
- BKSY 2.0M
- Earning Date
- RLAY 11-06-2025
- BKSY 11-06-2025
- Dividend Yield
- RLAY N/A
- BKSY N/A
- EPS Growth
- RLAY N/A
- BKSY N/A
- EPS
- RLAY N/A
- BKSY N/A
- Revenue
- RLAY $8,355,000.00
- BKSY $104,662,000.00
- Revenue This Year
- RLAY $27.30
- BKSY $15.43
- Revenue Next Year
- RLAY $7.43
- BKSY $34.03
- P/E Ratio
- RLAY N/A
- BKSY N/A
- Revenue Growth
- RLAY N/A
- BKSY N/A
- 52 Week Low
- RLAY $1.78
- BKSY $6.15
- 52 Week High
- RLAY $7.64
- BKSY $33.20
- Technical
- Relative Strength Index (RSI)
- RLAY 55.13
- BKSY 40.91
- Support Level
- RLAY $6.64
- BKSY $18.38
- Resistance Level
- RLAY $7.42
- BKSY $21.46
- Average True Range (ATR)
- RLAY 0.43
- BKSY 1.81
- MACD
- RLAY -0.11
- BKSY -0.83
- Stochastic Oscillator
- RLAY 30.97
- BKSY 10.04
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.